The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Safaryan A.S.

National Medical Research Center for Therapy and Preventive Medicine

Nebieridze D.V.

National Medical Research Center for Therapy and Preventive Medicine

Skripnikova I.A.

National Medical Research Center for Therapy and Preventive Medicine

Vygodin V.A.

National Medical Research Center for Therapy and Preventive Medicine

Nikonova K.V.

National Medical Research Center for Therapy and Preventive Medicine

Gorshkov A.Yu.

National Medical Research Center for Therapy and Preventive Medicine

Predictive significance of the calcium index in assessing cardiovascular risk

Authors:

Safaryan A.S., Nebieridze D.V., Skripnikova I.A., Vygodin V.A., Nikonova K.V., Gorshkov A.Yu.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2025;28(11): 79‑85

Read: 285 times


To cite this article:

Safaryan AS, Nebieridze DV, Skripnikova IA, Vygodin VA, Nikonova KV, Gorshkov AYu. Predictive significance of the calcium index in assessing cardiovascular risk. Russian Journal of Preventive Medicine. 2025;28(11):79‑85. (In Russ.)
https://doi.org/10.17116/profmed20252811179

Recommended articles:
Difficult intu­bation risk asse­ssment in bariatric surgery. Russian Journal of Anesthesiology and Reanimatology. 2025;(1):62-68
Two years expe­rience of using alirocumab in patients with dyslipidemia. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):216-220

References:

  1. Zhao D, Liu J, Wang M, et al. Epidemiology of cardiovascular disease in China: current features and implications. Nature Reviews. Cardiology. 2019; 16:203-212.  https://doi.org/10.1038/s41569-018-0119-4
  2. Mackenzie IS, Rogers A, Poulter NR, et al. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial. Lancet. 2022;400:1417-1425. https://doi.org/10.1016/S0140-6736(22)01786-X
  3. Gallone G, Baldetti L, Pagnesi M, et al. Medical therapy for long-term prevention of atherothrombosis following an acute coronary syndrome: JACC state-of-the-art review. Journal of the American College of Cardiology. 2018; 72:2886-2903. https://doi.org/10.1016/j.jacc.2018.09.052
  4. Taguchi I, Iimuro S, Iwata H, et al. High-dose versus low-dose pitavastatin in Japanese patients with stable coronary artery disease (REAL-CAD): a randomized superiority trial. Circulation. 2018;137:1997-2009. https://doi.org/10.1161/CIRCULATIONAHA.117.032615
  5. ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Rossijskij kardiologicheskij zhurnal. 2022;27(7):5155. (In Russ.). https://doi.org/10.15829/1560-4071-2022-5155
  6. Chiavaroli L, Nishi SK, Khan TA, et al. Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-analysis of Controlled Trials. Progress in Cardiovascular Diseases. 2018;61(1):43-53.  https://doi.org/10.1016/j.pcad.2018.05.004
  7. Prevention of chronic noncommunicable diseases in the Russian Federation. National Guideline 2022. Kardiovaskuljarnaja terapija i profilaktika. 2022; 21(4):3235. (In Russ.). https://doi.org/10.15829/1728-8800-2022-3235
  8. Urazalina SJ. Stratification of cardiovascular risk, current status of the problem. Rossijskij medicinskij zhurnal. 2012;18(5):39-45. (In Russ.).
  9. Solovey SP. Problems of stratification of cardiovascular risk and its reduction in primary prevention. Medicinskie novosti. 2018;(6):4-11. (In Russ.).
  10. Rodgers A, Ezzati M, Vander Hoorn S, et al. Distribution of Major Health Risks: Findings from the Global Burden of Disease Study. PLoS Medicine. 2004;1(1):e27.  https://doi.org/10.1371/journal.pmed.0010027
  11. Tasneem ZN, Ming-Sum L. Carotid intima-media thickness and plaque in cardiovascular risk assessment. JACC. Cardiovascular Imaging. 2014;7(10): 1025-1038. https://doi.org/10.1016/j.jcmg.2013.11.014
  12. Van der Bijl N, Joemai RM, Geleijns J, et al. Assessment of Agatston coronary artery calcium score using contrast-enhanced CT coronary angiography. AJR. American Journal of Roentgenology. 2010;63:195(6):1299-1305. https://doi.org/10.2214/AJR.09.3734
  13. Blaha MJ, Matsushita K. Coronary artery calcium: Need for more clarity in guidelines. JACC. Cardiovascular Imaging. 2017;10(2):154-156.  https://doi.org/10.1016/j.jcmg.2016.05.017
  14. Safaryan AS, Vygodin VA, Nebieridze DV, et al. Comparability of cardiovascular risk assessment according to the SCORE and the coronary artery calcium score (Agatston score). Kardiovaskuljarnaja terapija i profilaktika. 2023;22(9):3650. (In Russ.). https://doi.org/10.15829/1728-8800-2023-3650
  15. Arad Y, Spadaro LA, Goodman K, et al. Prediction of coronary events with electron beam computed tomography. Journal of the American College of Cardiology. 2000;36(4):1253-1260. https://doi.org/10.1016/s0735-1097(00)00872-x
  16. Rumberger JA, Brundage BH, Rader DJ, et al. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clinic Proceedings. 1999;74:243-252.  https://doi.org/10.4065/74.3.243
  17. Thelen M, Erbel R, Kreitner K-F, et al. Cardiac Imaging — a Multimodality Approach. Thieme. 2009.
  18. Elias-Smale SE, Proença RV, Koller MT, et al. Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. Journal of the American College of Cardiology. 2010;56:1407-1414. https://doi.org/10.1016/j.jacc.2010.06.029
  19. Johnson K, David A, Dowe D. The detection of any coronary calcium outperforms Framingham risk score as a first step in screening for coronary atherosclerosis. AJR. American Journal of Roentgenology. 2010;194(5):1235-1243. https://doi.org/10.2214/AJR.09.2487
  20. Temtem M, Mendonça MI, Gomes Serrão M, et al. Predictive improvement of adding coronary calcium score and a genetic risk score to a traditional risk model for cardiovascular event prediction. European Journal of Preventive Cardiology. 2024;31(6):709-715.  https://doi.org/10.1093/eurjpc/zwae005

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.